Kinoshita, Yuta
Arita, Seiya
Murazoe, Haruka
Kitamura, Kazuo
Ashizuka, Shinya
Inagaki-Ohara, Kyoko
Funding for this research was provided by:
Grants-in-Aid for Scientific Research (16K09316)
Article History
Received: 20 July 2018
Accepted: 30 September 2018
First Online: 10 October 2018
Compliance with ethical standards
:
: Kazuo Kitamura holds the stock of Himuka AM Pharma Corp. Yuta Kinoshita, Seiya Arita, Haruka Murazoe, Shinya Ashizuka, and Kyoko Inagaki-Ohara have no conflicts of interest to declare.
: All animal experiments were conducted in accordance with the guidelines of the Animal Research Committee of the Prefectural University of Hiroshima Animal Care and Use Committee.